Latest podcasts

 

Time-limited venetoclax and ibrutinib for patients with R/R CLL and undetectable MRD

(now playing ...)
Prof. Carsten Niemann, Department of Clinical Medicine, University of Copenhagen, Denmark
 

Talha Munir about ibrutinib plus venetoclax vs chlorambucil plus obinutuzumab for CLL patients

Dr. Talha Munir, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
All podcasts
X